ESSA Pharma Inc. is a clinical stage pharmaceutical company that develops unique therapies to treat prostate cancer. They are currently developing EPI-7386 for patients with metastatic castration-resistant prostate cancer. The company has collaboration agreements with major pharmaceutical companies like Janssen Research & Development and Astellas Pharma Inc.